Table 1.
Summary of clinicopathologic features
| Variables | Study groups |
|---|---|
| Age (years) | Median=62 (range: 17–88) |
| 60 year old and younger | 115 |
| Sex | |
| women | 128 |
| men | 124 |
| Race | |
| Asian | 7 |
| Black | 14 |
| Hispanic | 33 |
| White | 198 |
| Cytogenetics | |
| Favorable | 21 |
| Intermediate | 152 |
| Normal karyotype | 94 |
| Unfavorable | 79 |
| AML | |
| De novo | 192 |
| Preceding MDS or MDS/MPD | 33 |
| Therapy-related | 27 |
| FLT3 | |
| ITD | 53 |
| Wild type | 178 |
| Not tested | 21 |
| Response | |
| Complete remission | 136 |
| Relapsed | 51 |
| Failure | 116 |
| Death | |
| alive | 151 |
| dead | 101 |
| Follow-up (months) | Median=10 (range, <1–97 months) |